Cardioversion from Atrial Fibrillation without Prolonged Anticoagulation with Use of Transesophageal Echocardiography to Exclude the Presence of Atrial Thrombi
Warren J. Manning, David I. Silverman, Stephen Gordon, Harlan M. Krumholz, and Pamela S. Douglas
Background Because atrial thrombi are poorly detected by conventionalnoninvasive techniques such as transthoracic echocardiography,patients with prolonged atrial fibrillation usually receiveseveral weeks of oral anticoagulation therapy before cardioversionis attempted. We wondered whether transesophageal echocardiography,an accurate method of detecting atrial thrombi, would allowearly cardioversion to be performed safely if no thrombi wereidentified.
Methods A total of 669 consecutive patients admitted with thediagnosis of atrial fibrillation were screened. Patients wereexcluded if they were receiving long-term anticoagulation, ifthe duration of atrial fibrillation was two days or less, ifthey were not candidates for cardioversion, or if transesophagealechocardiography was contraindicated. Of 119 qualifying patients,94 agreed to participate; the average duration of atrial fibrillationwas 4.5 weeks. Participating patients underwent transthoracicechocardiography and transesophageal echocardiography followedby cardioversion if no thrombi were seen. Short-term anticoagulationwith heparin was used in 80 patients before cardioversion, and60 patients received warfarin for one month after cardioversion.
Results Fourteen atrial thrombi were identified in 12 patients(13 percent), and 12 of the 14 thrombi were visualized onlyon transesophageal echocardiography. Cardioversion was deferredin all 12 patients. Two of these 12 patients died suddenly;4 of the 10 surviving patients underwent uneventful cardioversionafter prolonged oral anticoagulation. Seventy-eight of the 82patients without thrombi underwent successful cardioversionto sinus rhythm (47 by means of antiarrhythmic drugs and 31by electrical cardioversion), all without long-term oral anticoagulation.None of these patients (95 percent confidence interval, 0 to4.6 percent) had an embolic event.
Conclusions In patients with atrial fibrillation of unknownor prolonged duration who are not receiving long-term anticoagulation,atrial thrombi are detected by transesophageal echocardiographyin only a small minority (13 percent in our study). Our preliminarydata suggest that if transesophageal echocardiography excludesthe presence of thrombi, early cardioversion can be performedsafely without the need for prolonged oral anticoagulation beforethe procedure.
Source Information
From the Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory of the Department of Medicine, Cardiovascular Division, Beth Israel Hospital and Harvard Medical School, Boston (W.J.M., S.P.F.G., H.M.K., P.S.D.), and the University of Connecticut Health Center, Cardiology Division, Farmington (D.I.S.).
Address reprint requests to Dr. Manning at the Cardiovascular Division, Beth Israel Hospital, 330 Brookline Ave., Boston, MA 02215.
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., Manning, W. J.
(2008). Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 546S-592S
[Abstract][Full Text]
Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace
8: 651-745
[Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol
48: 854-906
[Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol
48: e149-e246
[Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation
114: e257-e354
[Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation
114: 700-752
[Full Text]
Authors/Task Force Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA (Practice Guidelines) Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J
27: 1979-2030
[Full Text]
Strandberg, M., Raatikainen, M.J. P., Niemela, M., Luotolahti, M., Hartiala, J., Airaksinen, K.E. J.
(2006). Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation. Europace
8: 408-412
[Abstract][Full Text]
Donal, E., Yamada, H., Leclercq, C., Herpin, D.
(2005). The Left Atrial Appendage, a Small, Blind-Ended Structure: A Review of Its Echocardiographic Evaluation and Its Clinical Role. Chest
128: 1853-1862
[Abstract][Full Text]
Kuhl, H.P., Hanrath, P.
(2004). The impact of transesophageal echocardiography on daily clinical practice. Eur J Echocardiogr
5: 455-468
[Abstract][Full Text]
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., Manning, W. J.
(2004). Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 429S-456S
[Abstract][Full Text]
Hlatky, M., Go, A. S.
(2004). Economic implications of transesophageal echocardiography-guided cardioversion of atrial fibrillation. J Am Coll Cardiol
43: 1225-1227
[Full Text]
McNamara, R. L., Tamariz, L. J., Segal, J. B., Bass, E. B.
(2003). Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography. ANN INTERN MED
139: 1018-1033
[Abstract][Full Text]
Capucci, A., Aschieri, D.
(2003). Antiarrhythmic drug therapy: what is certain and what is to come. Eur Heart J Suppl
5: H8-H18
[Abstract]
Antonielli, E., Pizzuti, A., Palinkas, A., Tanga, M., Gruber, N. o., Michelassi, C., Varga, A., Bonzano, A., Gandolfo, N., Halmai, L.a., Bassignana, A., Imran, M. B., Delnevo, F., Csanady, M., Picano, E.
(2002). Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol
39: 1443-1449
[Abstract][Full Text]
Palinkas, A., Antonielli, E., Picano, E., Pizzuti, A., Varga, A., Nyuzo, B., Alegret, J.M., Bonzano, A., Tanga, M., Coppolino, A., Forster, T., Baralis, G., Delnevo, F., Csanady, M.
(2001). Clinical value of left atrial appendage flow velocity for predicting of cardioversion success in patients with non-valvular atrial fibrillation. Eur Heart J
22: 2201-2208
[Abstract]
(2001). Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J
22: 1852-1923
Fuster, V., Ryden, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Levy, S., McNamara, R. L., Prystowsky, E. N., Wann, L. S., Wyse, D. G., Gibbons, R. J., Antman, E. M., Alpert, J. S., Faxon, D. P., Fuster, V., Gregoratos, G., Hiratzka, L. F., Jacobs, A. K., Russell, R. O., Smith, S. C. Jr, Klein, W. W., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A.
(2001). ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol
38: 1266-1266
[Full Text]
Schmidt, H., von der Recke, G., Illien, S., Lewalter, T., Schimpf, R., Wolpert, C., Becher, H., Luderitz, B., Omran, H.
(2001). Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol
38: 778-784
[Abstract][Full Text]
Silverman, D. I., Manning, W. J.
(2001). Strategies for Cardioversion of Atrial Fibrillation -- Time for a Change?. NEJM
344: 1468-1470
[Full Text]
Albers, G. W., Dalen, J. E., Laupacis, A., Manning, W. J., Petersen, P., Singer, D. E.
(2001). Antithrombotic Therapy in Atrial Fibrillation. Chest
119: 194S-206S
[Full Text]
Stellbrink, C., Hanrath, P.
(2000). The optimal management of cardioversion of atrial fibrillation of flutter: still a 'stunning' problem. Eur Heart J
21: 795-798
Roijer, A, Eskilsson, J, Olsson, B
(2000). Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J
21: 837-847
[Abstract]
Mittal, S., Ayati, S., Stein, K. M., Schwartzman, D., Cavlovich, D., Tchou, P. J., Markowitz, S. M., Slotwiner, D. J., Scheiner, M. A., Lerman, B. B.
(2000). Transthoracic Cardioversion of Atrial Fibrillation : Comparison of Rectilinear Biphasic Versus Damped Sine Wave Monophasic Shocks. Circulation
101: 1282-1287
[Abstract][Full Text]
Corrado, G., Santarone, M., Beretta, S., Tadeo, G., Tagliagambe, L.M., Foglia-Manzillo, G., Spata, M., Miglierina, E., Acquati, F., Santarone, M.
(2000). Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8{middle dot}5-year experience. Europace
2: 119-126
[Abstract]
Al-Saady, N M, Obel, O A, Camm, A J
(1999). Left atrial appendage: structure, function, and role in thromboembolism. Heart
82: 547-554
[Abstract][Full Text]
Manning, W. J., Silverman, D. I., Oral, H., Morady, F.
(1999). Cardioversion of Atrial Fibrillation. NEJM
341: 1313-1313
[Full Text]
Ezekowitz, M. D., Levine, J. A.
(1999). Preventing Stroke in Patients With Atrial Fibrillation. JAMA
281: 1830-1835
[Abstract][Full Text]
Hardman, S. M C, Cowie, M. R
(1999). Fortnightly review: Anticoagulation in heart disease. BMJ
318: 238-244
[Full Text]
Corrado, G., Tadeo, G., Beretta, S., Tagliagambe, L. M., Manzillo, G. F., Spata, M., Santarone, M.
(1999). Atrial Thrombi Resolution After Prolonged Anticoagulation in Patients With Atrial Fibrillation: A Transesophageal Echocardiographic Study. Chest
115: 140-143
[Abstract][Full Text]
Eckman, M. H., Falk, R. H., Pauker, S. G.
(1998). Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation. Arch Intern Med
158: 1669-1677
[Abstract][Full Text]
Silverman, D. I., Manning, W. J.
(1998). Role of Echocardiography in Patients Undergoing Elective Cardioversion of Atrial Fibrillation. Circulation
98: 479-486
[Abstract][Full Text]
Veinot, J. P., Harrity, P. J., Gentile, F., Khandheria, B. K., Bailey, K. R., Eickholt, J. T., Seward, J. B., Tajik, A. J., Edwards, W. D.
(1997). Anatomy of the Normal Left Atrial Appendage : A Quantitative Study of Age-Related Changes in 500 Autopsy Hearts: Implications for Echocardiographic Examination. Circulation
96: 3112-3115
[Abstract][Full Text]
Cheitlin, M. D., Alpert, J. S., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davidson, T. W., Davis, J. L., Douglas, P. S., Gillam, L. D., Lewis, R. P., Pearlman, A. S., Philbrick, J. T., Shah, P. M., Williams, R. G., Ritchie, J. L., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Gibbons, R. J., Lewis, R. P., O'Rourke, R. A., Ryan, T. J.
(1997). ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography. Circulation
95: 1686-1744
[Full Text]
Halkin, A., Leibowitz, D., Hunn, R. H., Stroh, C. I., Shemesh, J., Motro, M., Hirani, N. A., Kaufman, J. L., Donnelly, W. J., Sirmon, M., Kreisberg, R. A.
(1996). Management of Acute Mesenteric Ischemia. NEJM
335: 594-596
[Full Text]
Collins, L. J., Silverman, D. I., Douglas, P. S., Manning, W. J.
(1995). Cardioversion of Nonrheumatic Atrial Fibrillation : Reduced Thromboembolic Complications With 4 Weeks of Precardioversion Anticoagulation Are Related to Atrial Thrombus Resolution. Circulation
92: 160-163
[Abstract][Full Text]
Daniel, W. G., Mugge, A.
(1995). Transesophageal Echocardiography. NEJM
332: 1268-1280
[Full Text]
Grimm, R. A., Black, I. W., Klein, A. L., Manning, W. J., Silverman, D. I., Douglas, P. S.
(1993). Transesophageal Echocardiography before Cardioversion. NEJM
329: 577-578
[Full Text]
(1993). A STRATEGY TO GUIDE CARDIOVERSION IN ATRIAL FIBRILLATION. JWatch General
1993: 1-1
[Full Text]
Daniel, W. G.
(1993). Should Transesophageal Echocardiography Be Used to Guide Cardioversion?. NEJM
328: 803-804
[Full Text]